Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
News|Articles|September 14, 2005
Milia
Author(s)Alexander K. C. Leung, MD
The whitish lesions on the nose and chin of this neonate are milia-tiny keratinous inclusion cysts that occur mainly on and around the nose.
Advertisement
The whitish lesions on the nose and chin of this neonate are milia-tiny keratinous inclusion cysts that occur mainly on and around the nose. Up to 40% of full-term infants have milia, which usually disappear spontaneously within a few weeks to a few months.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
Individualizing Obesity Treatment in Primary Care: An Expert Discussion
2
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
3
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
4
Type 2 Diabetes, Genetic Risk Linked to MASLD Cirrhosis Before Age 50
5